BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dong X, Sun Y, Li Y, Ma X, Zhang S, Yuan Y, Kohn J, Liu C, Qian J. Synergistic Combination of Bioactive Hydroxyapatite Nanoparticles and the Chemotherapeutic Doxorubicin to Overcome Tumor Multidrug Resistance. Small 2021;17:e2007672. [PMID: 33759364 DOI: 10.1002/smll.202007672] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhou M, Zhang J, Cai X, Dou R, Ruan L, Yang W, Lin W, Chen J, Hu Y. Tumor-Penetrating and Mitochondria-Targeted Drug Delivery Overcomes Doxorubicin Resistance in Lung Cancer. Chin J Polym Sci. [DOI: 10.1007/s10118-022-2775-4] [Reference Citation Analysis]
2 Wang X, Zhao Y, Hu Y, Fei Y, Zhao Y, Xue C, Cai K, Li M, Luo Z. Activatable Biomineralized Nanoplatform Remodels the Intracellular Environment of Multidrug-Resistant Tumors for Enhanced Ferroptosis/Apoptosis Therapy. Small 2021;:e2102269. [PMID: 34554637 DOI: 10.1002/smll.202102269] [Reference Citation Analysis]
3 Shao L, Hu T, Fan X, Wu X, Zhou F, Chen B, Tan S, Xu H, Pan A, Liang S, He Y. Intelligent Nanoplatform with Multi Therapeutic Modalities for Synergistic Cancer Therapy. ACS Appl Mater Interfaces 2022;14:13122-35. [PMID: 35286061 DOI: 10.1021/acsami.2c01913] [Reference Citation Analysis]
4 Chen J, Qiu M, Zhang S, Li B, Li D, Huang X, Qian Z, Zhao J, Wang Z, Tang D. A calcium phosphate drug carrier loading with 5-fluorouracil achieving a synergistic effect for pancreatic cancer therapy. J Colloid Interface Sci 2021;605:263-73. [PMID: 34332405 DOI: 10.1016/j.jcis.2021.07.080] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
5 Qiu M, Chen J, Huang X, Li B, Zhang S, Liu P, Wang Q, Qian ZR, Pan Y, Chen Y, Zhao J. Engineering Chemotherapeutic-Augmented Calcium Phosphate Nanoparticles for Treatment of Intraperitoneal Disseminated Ovarian Cancer. ACS Appl Mater Interfaces 2022;14:21954-65. [PMID: 35508299 DOI: 10.1021/acsami.2c02552] [Reference Citation Analysis]
6 Wu F, Shao R, Zheng P, Zhang T, Qiu C, Sui H, Li S, Jin L, Pan H, Jin X, Zou P, Cui R, Xie C. Isoalantolactone Enhances the Antitumor Activity of Doxorubicin by Inducing Reactive Oxygen Species and DNA Damage. Front Oncol 2022;12:813854. [DOI: 10.3389/fonc.2022.813854] [Reference Citation Analysis]
7 Tang Z, Tian W, Long H, Jiang S, Zhao J, Zhou J, He Q, Luo X. Subcellular-Targeted Near-Infrared-Responsive Nanomedicine with Synergistic Chemo-photothermal Therapy against Multidrug Resistant Cancer. Mol Pharmaceutics. [DOI: 10.1021/acs.molpharmaceut.1c00998] [Reference Citation Analysis]
8 Yin W, Tian L, Wang S, Zhang D, Guo S, Lang M. Co-delivery systems of paclitaxel prodrug for targeted synergistic therapy of breast cancer. Journal of Drug Delivery Science and Technology 2022. [DOI: 10.1016/j.jddst.2022.103157] [Reference Citation Analysis]
9 Gu M, Jiang L, Hao L, Lu J, Liu Z, Lei Z, Li Y, Hua C, Li W, Li X. A novel theranostic nanoplatform for imaging-guided chemo-photothermal therapy in oral squamous cell carcinoma. J Mater Chem B 2021;9:6006-16. [PMID: 34282440 DOI: 10.1039/d1tb01136g] [Reference Citation Analysis]
10 Yuan J, Ye Z, Zeng Y, Pan Z, Feng Z, Bao Y, Li Y, Liu X, He Y, Feng Q. Bifunctional scaffolds for tumor therapy and bone regeneration: Synergistic effect and interplay between therapeutic agents and scaffold materials. Mater Today Bio 2022;15:100318. [PMID: 35734197 DOI: 10.1016/j.mtbio.2022.100318] [Reference Citation Analysis]
11 Huang SH, Peng S, Wang QY, Hu QH, Zhang RQ, Liu L, Liu Q, Lin J, Zhou QH. Gold nanorods conjugated with biocompatible zwitterionic polypeptide for combined chemo-photothermal therapy of cervical cancer. Colloids Surf B Biointerfaces 2021;207:112014. [PMID: 34391166 DOI: 10.1016/j.colsurfb.2021.112014] [Reference Citation Analysis]
12 Zhang H, Yu J, Ma L, Zhao Y, Xu S, Shi J, Qian K, Gu M, Tan H, Xu L, Liu Y, Mu C, Xiong Y. Reversing multi-drug resistance by polymeric metformin to enhance antitumor efficacy of chemotherapy. Int J Pharm 2022;:121931. [PMID: 35750278 DOI: 10.1016/j.ijpharm.2022.121931] [Reference Citation Analysis]